# MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

> **NCT04599218** · NA · UNKNOWN · sponsor: **Ardeshir Rastinehad** · enrollment: 1586 (estimated)

## Conditions studied

- Prostate Disease
- Elevated Prostate Specific Antigen
- Family History of Prostate Cancer
- Positive Digital Rectal Exam
- Prostate Cancer

## Interventions

- **OTHER:** Prostate Biopsy
- **OTHER:** MR US Fusion Guided Prostate Biopsy
- **DEVICE:** MR/TRUS Fusion Guided Prostate Biopsy

## Key facts

- **NCT ID:** NCT04599218
- **Lead sponsor:** Ardeshir Rastinehad
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-21
- **Primary completion:** 2025-10-15
- **Final completion:** 2026-01-15
- **Target enrollment:** 1586 (ESTIMATED)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04599218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04599218, "MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04599218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*